Corporate News 19-Sep-22
Indoco Remedies' AnaCipher CRO successfully clears USFDA audit
Indoco Remedies announced today that its Clinical Research Organisation, AnaCipher, located in Hyderabad, was inspected by the United States Food and Drug Administration from 12 to 16 September 2022. The clinical phase of inspection covered three BA/BE studies submitted by clients to the USFDA and was successfully concluded with zero 483s.
Previous News
Board of Indoco Remedies recommends final dividend
( Corporate News - 22-May-25 21:09 )
Indoco Remedies receives USFDA approval for Canagliflozin and Metformin Hydrochloride Tablets
( Corporate News - 07-Jun-24 08:40 )
Indoco Remedies to convene AGM
( Corporate News - 31-Aug-23 14:05 )
Indoco Remedies gains after receiving USFDA nod for type 2 diabetes drug
( Hot Pursuit - 06-Jun-24 14:47 )
Indoco Remedies to acquire stake in Kanakal Wind Energy
( Hot Pursuit - 17-Aug-22 10:44 )
Warren Remedies commences commercial production of its greenfield units at Aurangabad
( Corporate News - 26-Mar-24 09:34 )
Indoco Remedies to conduct AGM
( Corporate News - 23-Aug-22 20:11 )
Volumes spurt at Indoco Remedies Ltd counter
( Hot Pursuit - 26-May-21 11:00 )
Indoco Remedies declines after US FDA classifies Goa plant inspection as OAI
( Hot Pursuit - 05-Jun-23 09:20 )
Indoco Remedies slips after weak Q4 numbers
( Hot Pursuit - 24-Jun-20 14:05 )
Indoco Remedies announces board meeting date
( Corporate News - 19-Oct-20 13:43 )
Other Stories
Vintage Coffee And Beverages to hold board meeting
01-Jul-25 18:44
Hind Rectifiers to convene AGM
01-Jul-25 18:44
Lupin carves-out its LupinLife Consumer Healthcare
01-Jul-25 18:39
Lupin receives USFDA approval for Loteprednol Etabonate Ophthalmic Gel
01-Jul-25 18:37
LTIMindtree introduced its GCC-as-a-Service
01-Jul-25 18:34
Hyundai Motor India sells 60,924 units in June'25
01-Jul-25 18:33
Maruti Suzuki India records 6.26% decline in June sales
01-Jul-25 18:30
RateGain forges strategic partnership with Cloudbeds
01-Jul-25 15:24
Aurionpro Solutions announces strategic win with a leading UK-based financial institution
01-Jul-25 15:17
Tata Motors Q1 sales decline 8% to 2.10 lakh units
01-Jul-25 15:08
Back
Top
